Kazuhisa Yokota

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Cholangitis with septic shock caused by Raoultella planticola

Kazuhisa Yokota, Harumi Gomi, Kentaro Sugano et al. · Journal of Medical Microbiology · 2011 · 50 citations

Microbial Disease, Klebsiella Pneumoniae, Klebsiella Planticola +9

Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study

Nobuaki Matsunaga, Kayoko Hayakawa, Yusuke Asai et al. · The Lancet Regional Health - Western Pacific · 2022 · 43 citations · Full text

Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

Shinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura et al. · International Journal of Infectious Diseases · 2022 · 20 citations · Full text

Covid-19 Pandemic, Clinical Epidemiology, Antiviral Therapy +10